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Abstract
Objectives: This study was conducted to evaluate differences between 915-MHz and 2.45-GHz micro-
wave ablation (MWA) systems in the ablation of hepatic tumours.
Methods: A retrospective analysis of patients undergoing hepatic tumour MWA utilizing two different
systems over a 10-month period was carried out.
Results: Data for a total of 48 patients with a mean age of 58  1.24 years were analysed. A total of 124
tumours were ablated; 72 tumours were ablated with a 915-MHz system and 52 with a 2.45-GHz system.
Mean tumour diameters were 1.7 0.1 cm in the 915-MHz group and 2.5 0.2 cm in the 2.45-GHz group
(P < 0.01). Mean ablation time per burn was 8.1  0.3 min in the 915-MHz group and 4.0  0.1 min in the
2.45-GHz group (P < 0.01). The mean number of burns per lesion was 2.0  0.1 in the 915-MHz group
and 1.7  0.1 in the 2.45-GHz group (P < 0.05). The mean ablation time per lesion was 9.7  0.7 min in
the 915-MHz group, and 6.6  0.6 min in the 2.45-GHz group (P < 0.01). The 2.45-GHz system
demonstrated a better correlation between ablation time and tumour size (r2 = 0.6222) than the 915-MHz
system; (r2 = 0.0696). Mean total energy applied per lesion, and energy applied per cm, were greater with
the 915-MHz system (P < 0.05 and P < 0.01, respectively). Total energy applied per lesion was similarly
correlated for the 2.45-GHz (r2 = 0.6263) and 915-MHz (r2 = 0.7012) systems. Mean total energy applied
per cm/min was greater with the 2.45-GHz system (P < 0.05).
Conclusions: Both 915-MHz and 2.45-GHz MWA systems achieve reproducible hepatic tumour abla-
tion. The 2.45-GHz system achieves equivalent, but more predictable and faster ablations using a single
antenna system.
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Introduction
Liver-directed locoregional therapyhas significantly improved sur-
vival in patients presenting with hepatic tumours who are not
candidates for resection, as well as in patients with specific primary
liver cancers who do not undergo liver transplantation.1,2 Locore-
gional therapy has evolved and expanded significantly over the past
two decades and now includes percutaneous ethanol or acetic acid
injections, cryoablation, transarterial chemoembolization, tran-
sarterial radiotherapy, and thermal and non-thermal ablation.1,2
The popularity of thermal ablation approaches continues to grow,
as is demonstrated by the frequent utilization of radiofrequency
ablation (RFA) and the increasingly favoured microwave ablation
(MWA). Indeed, the application of thermoablativemodalities as an
effective means of primary and secondary hepatic tumour control
is widely supported in the literature.1,3–6
The application of a microwave field to tissue causes dipolar
molecules (primarily water) to align and realign according to the
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variable electromagnetic field. Rapid changes in dipole rotation
produce frictional heating,1 which results in tissue degeneration.7
The physics of MWA heating are complex and are attributed to
highly interdependent antenna–tissue interactions in the ‘near
field’ (the term derived frommicrowave physics and often used by
surgeons to describe the ablation zone, which encompasses the
near field).8 This is different from what happens in RFA, in which
heating is primarily resistive as a result of the passage of current,
and thereforemuchmore susceptible to electric sinks such as blood
vessels and conductive foreign bodies.2,9 As a result, a more focal
ablation, which deposits greater energy in the target zone, can be
applied to a tumour mass and surrounding tissue using MWA
(compared to RFA), leading to increased maximal local ablation
energy deposition and temperatures following ablation.9–11
Both 915-MHz and 2.45-GHz MWA systems are commercially
available in the USA. The 915-MHz generator was introduced by
Vivant Medical, Inc. (Mountain View, CA, USA) and approved by
the Food and Drug Administration (FDA) in 2003. This system
typically employs between one and three 13-gauge antennae,
arranged in a customizable, multi-antenna configuration.1 Each
antenna for this system connects to an independent, non-
synchronized microwave generator and thus this arrangement
should not be confused with an antenna array.12,13 An observed
decrease in power-handling ability leads to notably restricted
power delivery characteristics as a result of the impedance mis-
match between the cable and the antenna.6,14,15 A 2.45-GHz system
using a different single-antenna design was developed byMicrosu-
lis Medical Ltd (Denmead, UK) and approved by the FDA in 2006.
In contrast to the 915-MHz system, the 2.45-GHz system uses a
single antenna connected to a generator set to deliver 100watts (W)
of power.16 Although in essence both systems produce the desired
tissue destruction, it is important to critically evaluate the technical
differences between systems to gain a clear understanding of the
amount of energy that is applied to a treated lesion.
The radiation efficiency of an antenna depends (largely) on
how closely the frequency matches water molecule resonance. As
such the 2.45-GHz system is more efficient than the correspond-
ing 915-MHz antenna.17 For example, to achieve a 5-cm diameter
ablation zone with the 915-MHz system, 45 W is delivered via
each of three antennae and requires approximately 10 min of
application.1,16 By contrast, the 2.45-GHz system, set to deliver
100 W via a single antenna, would require 4–6 min of applica-
tion.1,16 Institutionally, both systems have been employed clinically
in both open and laparoscopic approaches to treat primary and
secondary hepatic tumours.
The aim of this study was to evaluate a single centre’s clinical
experience of using these systems and to directly compare the
technical aspects of the two systems.
Materials and methods
Institutional review board approval was obtained at the Carolinas
Medical Center (CMC), Charlotte, NC, USA. A prospectively col-
lected database was utilized to retrospectively review data for all
patients with liver malignancies, primary or metastatic, who
underwent MWA therapy at CMC between June 2008 and March
2009.
Patient demographics (age, gender, primary indication for
treatment, number of lesions) were recorded in parallel with
operative details (tumour diameter MWA system employed,
power settings, duration of application, number of applications
per lesion). Ablation times and tumour sizes were also analysed to
allow a direct comparison of the two systems that would consider
the actual total energy applied per burn, the total energy applied
per lesion, and the total energy applied per centimetre diameter.
Calculations were performed to determine whether any signifi-
cant difference was present as a result of estimated power loss. To
estimate power loss, the power displayed on the screen is con-
verted to actual power at the device tip by multiplying the power
displayed on the screen by a factor of 0.76 for the 915-MHz system
and 0.78 for the 2.45-GHz system.8,18
All data were collected from the patients’ electronic medical
records. Data were analysed using GraphPad prism Version 5.0
(GraphPad Software, Inc., San Diego, CA, USA) and stratified by
the issue of interest, which was treatment type (915-MHz system
or 2.45-GHz system). Significance was indicated by a P-value of <
0.05.Groups were compared using Student’s t-tests and analysis of
variance (anova) with Tukey’s honestly significant differences
(HSD) post hoc tests. Outcomes of interest included: energy
applied per burn; total energy applied per lesion, and total abla-
tion time per lesion for both absolute power and adjusted for
estimated power loss with each system.
Results
Data for 48 patients (28 male, 20 female) were reviewed in this
study. Themean standard deviation (SD) age of the patients was
58  1.24 years (median: 61 years; range: 35–82 years). Thirty-
three patients underwent a laparoscopic procedure and 15 an open
procedure.Anopenapproachwas chosenwhena concomitant liver
resection could not be completed laparoscopically, or a separate
procedure (e.g. colectomy) was undertaken simultaneously. Thir-
teen concomitant hepatic resectionswere performed (three laparo-
scopic and 10 open).Concomitant liver resectionwas performed at
the discretion of the attending surgeon when the patient had
multiple lesions and adequate liver reserve. Final pathology
revealed hepatocellular carcinomas (HCCs) in 18 patients, color-
ectalmetastases in 12 patients and other liver lesions in 18 patients.
Using the 915-MHz system, duration of total ablation time per
lesion ranged from 2 min to 40 min and utilized one to three
antennae per burn for lesions measuring 0.3–5.0 cm in diameter.
Using the 2.45-GHz system, total ablation time was 2–24 min for
lesions measuring 0.3–6.5 cm in diameter. Up to four burns per
lesion were performed with either system based on lesion size and
appearance on ultrasound after each burn to ensure complete
ablation. In total, 124 tumours were ablated (Table 1). All ablation
992 HPB
HPB 2013, 15, 991–996 © 2013 International Hepato-Pancreato-Biliary Association
times were greater for the 915-MHz than the 2.45-GHz system
(Table 1).
On in-depth analysis, total ablation time and tumour diameter
demonstrated a closer correlation for the 2.45-GHz system (r2 =
0.622) compared with the 915-MHz system (r2 = 0.070) (Fig. 1). It
should be noted that five tumours measuring >5 cm in diameter
were ablatedwith the 2.45-GHz system,whereas no tumours of this
size were ablated using the 915-MHz system. Mean total energy
application per lesion was similarly correlated for the 2.45-GHz
system (r2 = 0.625) and the 915-MHz system (r2 = 0.681) (Fig. 2).
Finally, the evaluation of energy applied adjusted for estimated
power loss revealed a significant difference for energy applied per
cm for both systems (P < 0.05 for the 2.45-GHz system;P < 0.01 for
the 915-MHz system) (Fig. 3), but no differences for total energy
applied or energy applied per cm/min (P > 0.05).
Discussion
This report summarizes an experience with two different methods
of MWA in the treatment of hepatic tumours, using 915-MHz and
2.45-GHz systems, over a 10-month period. The 915-MHz system
allows the performance of up to three simultaneous ablations
because this system comprises three separate 915-MHz generators.
The authors prefer this system formultiple small-volume ablations
because, in their experience, this system provides a comparatively
smaller ablation zone. Recall that an observed decrease in power-
handling ability leads to notably restricted power delivery charac-
teristics as a result of the impedance mismatch between the cable
and antenna. This, in turn, results in decreased energy delivery
efficiency with the 915-MHz system. Conversely, the 2.45-GHz
systemhas a higher power output as a result of increased efficiency,
Table 1 Tumour and burn characteristics in patients treated with the 915-MHz and 2.45-GHz microwave ablation systems
Parameter Microwave ablation system P-value
915-MHz 2.45-GHz
Number of tumours ablated 72 52 N/A
Number of lesions per patient, mean 3 2 0.25
Lesion size, cm, mean  SD (median) 1.66  0.12 (1.5) 2.46  0.22 (2.0) <0.01
Power per burn, W 45 W (n = 69)
40 W (n = 3)
100 W (n = 45)
80 W (n = 7)
Number of antennae used per burn 1 antenna: 37%
2 antennae: 24%
3 antennae: 39%
1
Number of burns per lesion, mean  SD (median) 2.03  0.11 (1) 1.65  0.14 (1) <0.05
Ablation time per antenna burn, min, mean  SD (median) 8.19  0.31 (10) 4.00  0.14 (4) <0.01
Energy applied per burn, J, mean  SD (median) 25 278  1910 (27 000) 22 920  1018 (24 000) 0.33
Total energy applied per lesion, J, mean  SD (median) 54 719  6080 (40 500) 38 818  3895 (24 000) <0.05
Energy applied per cm, J, mean  SD (median) 32 111  1975 (27 000) 17 750  1540 (14 057) <0.01
Total ablation time per lesion, min, mean  SD (median) 9.66  0.71 (10.0) 6.56  0.64 (4.5) <0.05
Total energy applied per cm/min/lesion, J, mean  SD (median) 2510  227 (1800) 3645  433 (2864) <0.05
SD, standard deviation; N/A, not applicable.
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Figure 1 Total ablation time according to lesion size using the 2.45-
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Figure 2 Total energy applied according to lesion size using the
2.45-GHz and 915-MHz microwave ablation systems
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which results in the ablation of a comparatively larger zone in a
shorter timeperiod.However, this systemcomprises one generator,
which necessitates serial ablations. As a result, the authors prefer
this system for large-volume and single lesion ablations.
The data revealed that the ablation time per burn required by
the 2.45-GHz system was significantly shorter than that required
using the 915-MHz system (4.0  0.1 min/burn versus 8.2 
0.3 min/burn; P < 0.01), even when total ablation time per lesion
is considered (6.6  0.6 min versus 9.7  0.7 min; P < 0.05).
Although the energy applied per burn does not differ significantly
between the systems (P = 0.33), the energy applied per lesion (P <
0.05) and energy applied per cm (P < 0.01) were greater with the
915-MHz system. Conversely, the total energy applied per
cm/min/lesion was greater for the 2.45-GHz (3645  434 J/cm/
min) than for the 915-MHz (2510  228 J/cm/min) system (P <
0.05). Thus, the 2.45-GHz system delivered more energy per burn
than the 915-MHz systemwhen power loss was taken into account
as a result of the higher frequency employed (optimum on the
frequency scale), and provided a correspondingly shorter ablation
time. However, this effect is not evident after adjusting for total
energy applied per lesion as the total energy delivered is greater
with the 915-MHz system because this system employs more
antennae per burn, and more burns per lesion.
Less time was required for ablation with the 2.45-GHz system
given equal power as a result of higher antenna power efficiency.
Effective power delivery was also greater for the 2.45-GHz system
than for the 915-MHz system in a single-antenna burn. This effect
reflects not only differences between generators, but also differences
in efficiency of energy transfer from MWA to heat within the abla-
tion zone.Additionally, substantiallymore ‘radiation’ and heating in
the near field than in the surrounding ‘far field’ occurs when using
the 2.45-GHz than when using the 915-MHz system.8
Estimations of power loss for both the 915-MHz and 2.45-GHz
systems are rudimentary as the reflections (which reduce energy
delivery) vary according to impedance mismatches.18 Further,
impedance for MWA derives from the interaction of the antenna
with the tissue because tissue impedance changes as it undergoes
ablation.8,18 It is the impedance of the antenna submerged in tissue
and the impedance mismatch between the transmission cable to
the antenna and the antenna itself that change.8,18 These effects, in
turn, change the efficiency of power delivery.8 Put another way,
reflection loss is related to impedance mismatch between a sys-
tem’s impedance (usually 50 Ohm for the cable and generator)
and the antenna’s impedance.8 This mismatch depends on
antenna-characteristic impedance, as well as on the electrical
properties of surrounding substances within the near field and
their temperature.8 However, these estimates of power loss serve to
demonstrate the overriding concept that power loss occurs with
both systems, but this loss does not substantially affect the total
energy applied to lesions as the systems are currently employed in
clinical practice.
The pursuit of the ideal energy source for the thermoablation of
hepatic tumours is ongoing. The perfect ablative technology
should provide a reliable, predictable, powerful source of energy
for tumour destruction, regardless of local tissue conditions and
the surrounding environment.10,19 In selecting the most appropri-
ate system for MWA, several factors must be considered, including
lesion location, energy deposition and associated application
time. It is important to realize the differences in the mechanism of
heat generation at different frequencies, which can be translated to
provide increased, more focal energy delivery per burn at the
centre of the ablation zone, partly as a result of decreased
perfusion-related energy dissipation.15 Similarly, at lower frequen-
cies the microwave near field is smaller and surrounded by a far
field, which results in a concentration of energy in a smaller region
and increased penetration.17
The 915-MHz system has several positive compensatory fea-
tures, including the fact that multiple antennae can be employed
concomitantly to allow the creation of a customizable microwave
near-field configuration. This can be especially useful when the
ablation must be tailored secondary to surrounding anatomic
landmarks, such as when a lesion presents near hepatic veins or
close to the confluence of the left and right hepatic ducts. This
ability to use multiple antennae also allows for multiple small
ablations to be performed simultaneously, such as in multiple
small colorectal metastases.
Nevertheless, there are several reasons why the 915-MHz system
is less efficient in terms of energy deposition, as a result of which
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Figure 3 (a) Energy applied per cm of lesion using the 915-MHz
system and the 915-MHz system adjusted for estimated power loss.
(b) Energy applied per cm of lesion using the 2.45-GHz system and
the 2.45-GHz system adjusted for estimated power loss
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it requires increased application time (although it is still faster
than RFA).2 At this lower frequency more energy is dissipated in
perfusion (an increased amount is wasted) secondary to the less
focal nature of the energy deposition pattern. Moreover, the small
coaxial cable employed within the 915-MHz system also results in
more power loss as a result of coaxial transmission line losses.8 A
‘comet effect’ is a primarily electromagnetic effect in which the
near-field configuration looks like a comet tail, and thus heating
happens in this pattern and occurs as a result of hot gases pushing
back up the applicator tract with resultant heating of the antenna
tip.20 This shaft heating is caused by reflection of the microwave
energy secondary to an impedance mismatch, as previously dis-
cussed, as well as by a negligible conduction of heat from the
ablation zone along the shaft, which must be cooled when using
an antenna percutaneously to avoid skin burns.8,21
Likewise, the 2.45-GHz system offers certain clinical advan-
tages, including a shorter ablation time (for the same wattage) and
the creation of a reproducible 4-cm MWA with each application.
Because of this efficiency, the 2.45-GHz system is better suited
than the 915-MHz system to the ablation of single, large lesions
(e.g. focal HCC tumours of >5 cm). Additionally, because this
system is subject to minimal power loss (secondary to a low degree
of shaft heating and good insulation of the shaft by a fluorinated
ethylene polymer sheath), there is no risk for skin burns from the
antenna shaft.8,18,21
Upon initial evaluation, there appear to be several distinct
advantages associated with the 2.45-GHz system. However, on
closer inspection, it is apparent that more total energy is applied
per lesion with the 915-MHz system secondary to its design.Given
the particular strengths and weaknesses of each of these MWA
systems, it is recommended that the surgeon should choose the
system based on lesion size and location, and with consideration
for surrounding structures.
It is important to highlight the potential limitations of this
study, such as its retrospective nature and the diversity of the
primary and metastatic liver cancers present in the study popula-
tion. In conducting similar comparative studies in the future, the
use of stratified selection criteria for patients and underlying
pathologies will be necessary to fully evaluate the relative benefits
and limitations of different MWA systems.
Finally, this study did not include a cost-effectiveness analysis
because it focused on technical differences between systems.
Reported generator costs are essentially similar, at US$35 000 and
US$40 000 for the 915-MHz and 2.45-GHz systems, respectively,
but three 915-MHz generators are typically required. The cost of
using one antenna is US$1815 for the 915-MHz system and
US$1950 for the 2.45-GHz system. Thus, the cost of using three
915-MHz antennae is potentially triple that of using a single 2.45-
GHz antenna. However, actual costs are determined by a contract
between the institution and the individual distributor.An accurate
cost comparison would also need to consider the monetary
savings to be derived from the decrease in operating room time
associated with the use of the 2.45-GHz system.
In conclusion, the use of emerging and effective thermoablative
modalities continues to expand the treatment options available to
patients presenting with hepatic tumours. The current study con-
firms that MWA delivered by either of the two systems evaluated
in this study is a clinically efficacious therapy. Further, the 2.45-
GHz system achieves equivalent, but more predictable and faster
ablations, given a single-antenna system.
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